Asia Pacific Alopecia Treatment Market, By Treatment Type (Topical Drugs (Creams, Oils, Gels, Shampoo, Lotion, Foam), Oral Drugs, Injectables (Platelet Rich Plasma, Steroid Injections, Injectable Filler), Hair Transplant Services, Low-Level Laser Therapy)

Asia Pacific Alopecia Treatment Market, By Treatment Type (Topical Drugs (Creams, Oils, Gels, Shampoo, Lotion, Foam), Oral Drugs, Injectables (Platelet Rich Plasma, Steroid Injections, Injectable Filler), Hair Transplant Services, Low-Level Laser Therapy), By Disease Indication (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), By End User (Hospitals, Dermatologic and Trichology Clinics, Home care settings, Aesthetic Clinics), and By Countries (China, Japan, Australia, New Zealand, Malaysia, India, Singapore, Vietnam, Philippines, Rest of APAC) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Alopecia areata is a common autoimmune disorder that results in unpredictable hair loss. Alopecia is the common autoimmune disorder, which causes hair loss or sometimes it may lead to baldness. Cicatricial alopecia is the condition characterized by hair loss accompanied by the formation of scars. Alopecia is classified into alopecia areata, androgenic alopecia, alopecia totalis, and cicatricial alopecia. In this case, the body attacks its own anagen hair follicles and suppresses or stops hair growth.

Restraints of the Asia Pacific Alopecia Treatment Market
Major factors hampering the growth of the Asia Pacific alopecia treatment market during the forecast period constitutes of limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs.
Key features of the study:
This report provides in-depth analysis of the Asia pacific alopecia treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the Asia pacific alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The Asia pacific alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Asia Pacific Alopecia Treatment Market, By Treatment Type:
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
Asia Pacific Alopecia Treatment Market, By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
Asia Pacific Alopecia Treatment Market, By End User:
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Asia Pacific Alopecia Treatment Market, By Countries:
China
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Japan
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Australia
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
India
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Malaysia
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Singapore
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Vietnam
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Philippines
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Rest of APAC
By Treatment Type
Topical Drugs
Creams
Oils
Gels
Shampoo
Lotion
Foam
Oral Drugs
Injectables
Platelet Rich Plasma
Steroid Injections
Injectable Filler
Hair Transplant Services
Low-Level Laser Therapy
By Disease Indication:
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
By End User
Hospitals
Dermatologic and Trichology Clinics
Home care settings
Aesthetic Clinics
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Merck & Co., Inc.
Johnson & Johnson, Inc.
Pfizer, Inc.
Dr. Reddy’s Laboratories Ltd.
Cipla Ltd.
Cellmid Ltd.
The Himalaya Drug Company
Taisho Pharmaceutical Holdings Co. Ltd.
Shiseido Co., Ltd.
Other Major Players
“*” marked represents similar segmentation in other categories in the respective section.